Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy
Ryungsa Kim(Hiroshima Institute of Technology), Tetsuya Toge(Hiroshima University), Kazuaki Tanabe(Hiroshima University), Manabu Emi(Hiroshima University)
Cited by 110
Related Papers
Cancer immunoediting from immune surveillance to immune escape
|Immunology|2007|1k
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
The long-term survival of stage IV gastric cancer patients with conversion therapy
|Gastric Cancer|2017|168
Targeted therapy against Bcl-2-related proteins in breast cancer cells
|Breast Cancer Research|2005|114